Condition: Infectious Diseases · Antimicrobial Drug Resistance · Sponsor: Bugworks Research Inc.
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.
This description comes directly from the study's public registry record.
Harish Kaushik Kotakonda, PhD · +91-9550288659 · harish@bugworksresearch.com
Balasubramanian V, PhD · bala@bugworksresearch.com
Always discuss trial participation with your own doctor first.
| Nucleus Network | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07029932